Feverfew: benefits, dosage, contraindications
Other name(s)
Partenelle, Feverfew, Pyrethrum
Scientific name(s)
Tanacetum parthenium, Chrysanthemum parthenium, Pyrethrum parthenium
Family or group:
Plants
Active ingredients:
Parthenolides
Melatonin
Camphor
Indications
Scoring methodology
EFSA approval.
Migraine ✪✪✪✪✪
Most clinical research shows that taking feverfew can reduce the frequency of migraines and decrease symptoms of pain, nausea, vomiting, and sensitivity to light and sound. It may be more effective in patients who have fairly frequent migraine attacks. A Cochrane systematic review of several randomized, double-blind, placebo-controlled trials concluded that the evidence was insufficient to determine whether feverfew was superior to placebo in reducing the frequency or incidence of migraines, the severity of nausea, or the severity of migraines. A closer look at the studies shows mixed results, varying methodological quality, and use of different dosing regimens, routes of administration, and extracts. These conflicting findings may reflect differences in the feverfew plants harvested or differences in the bioavailability of commercially prepared feverfew products. Dosing regimens that have shown benefit include feverfew powder 50-150 mg once daily for up to 4 months and a carbon dioxide feverfew extract (MIG-99) 2.08-18.75 mg three times daily for 3 to 4 months. ESCOP and EMA indicate the use of feverfew as a traditional medicine for the prevention of migraines.
Posologie
Synergies
Feverfew for Preventing Migraine
European Union herbal monograph on Tanacetum parthenium (L.) Schultz Bip., herba
An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache
Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study
Evidence-based guidelines for migraine headache (an evidence-based review)
Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase
Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicenter, placebo-controlled study
A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine
Randomized double-blind placebo-controlled trial of feverfew in migraine prevention
Efficacy of Feverfew as a Prophylactic Treatment for Migraine
The Efficacy and Safety of Tanacetum Parthenium (Feverfew) in Migraine Prophylaxis--A Double-Blind, Multicenter, Randomized Placebo-Controlled Dose-Response Study
A combination of coenzyme Q10, feverfew, and magnesium for migraine prophylaxis: a prospective observational study
E/S/C/O/P: 2nd Edition of the ESCOP Monographs
The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: a randomized study
Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Dysmenorrhea ✪✪✪✪✪
Thanks to its antispasmodic action, feverfew has traditionally been used to regulate the menstrual cycle.
Posologie
Properties
Anti-inflammatory




Feverfew has anti-inflammatory properties that can be explained by several mechanisms. First, it may reduce the activity of certain enzymes and substances involved in inflammation, such as proteases and leukotrienes. Next, feverfew appears to prevent the formation of prostaglandins, substances important in the inflammatory process. It acts by blocking an enzyme, phospholipase, which stops the release of a key molecule in the creation of these prostaglandins. Laboratory research has shown that some components of feverfew, such as the parthenolide, limit the production of one of these prostaglandins, PGE2. Parthenolide, in particular, targets a specific inflammation-related enzyme, COX-2, as well as various pro-inflammatory molecules. Animal studies have also shown that feverfew extracts have anti-inflammatory effects and reduce pain sensitivity, without involving opioid receptors. These effects could be due to an influence on certain molecules present in vascular cells. Although parthenolide is considered an active anti-inflammatory constituent, laboratory research suggests that feverfew depleted in parthenolide also has anti-inflammatory effects, such as inhibition of pro-inflammatory enzymes, cytokines, and prostaglandins.
Usages associés
Neurological




Feverfew is recognized for its potential benefits against migraine. It was once believed that parthenolide, one of its components, was essential for combating migraines, and that a concentration of at least 0.2% was necessary. However, a study with an extract containing 0.35% parthenolide did not confirm its effectiveness, suggesting that other components may be required. The mechanisms of action of feverfew in migraine prevention are not fully understood. The plant appears to affect certain enzymes and substances related to inflammation, such as proteases and leukotrienes, and to block the production of prostaglandins, which are involved in inflammation and pain. Preliminary research indicates that feverfew extracts may prevent contraction of vascular smooth muscle, a potentially beneficial effect for relieving migraines. The chrysanthenyl acetate, another substance present in the plant, is also suggested as an active component, having analgesic properties and potentially inhibiting prostaglandin formation. Feverfew also contains melatonin, which may contribute to its pharmacological effects. It should be noted that the fresh or dried leaves of the plant contain more melatonin than commercially prepared standardized tablets.
Usages associés
Anticancer




Feverfew and its constituents, particularly the parthenolide, have shown promising effects in the fight against cancer according to laboratory research. These studies suggest that feverfew could slow the growth of cancer cells and even lead them to self-destruct, a process known as apoptosis. Parthenolide, a key component of feverfew, appears to interfere with the life cycle of cancer cells, halting them or pushing them toward differentiation, then triggering their programmed death. This compound has the potential to induce apoptosis in several types of cancer cells while being non-toxic to normal cells. It also acts on certain transcription factors in cells, such as the signal transducer and activator of transcription (STAT) proteins, which are involved in cell growth, differentiation, and death. Parthenolide reduces the expression of genes that inhibit apoptosis, but this action appears to be specific to cancer cells. Furthermore, parthenolide has a different effect on cancer cells compared to normal cells with regard to reactive oxygen species (ROS). In cancer cells, it increases ROS levels, thereby promoting their death. In contrast, in non-cancerous cells, it acts as an antioxidant, reducing ROS levels. Finally, more recent research has revealed that parthenolide can trigger apoptosis in cancer cells by causing mitochondrial dysfunction. This mechanism has been shown to significantly slow tumor growth and angiogenesis, which is the formation of new blood vessels to feed the tumor, in cancer models. This proapoptotic action appears to be linked to activation of a key protein, p53, and to an increase in ROS production.
Antihistamine




Feverfew is traditionally used for allergies. In laboratory studies on rat peritoneal mast cells, feverfew extract demonstrated a dose-dependent inhibition of histamine release.nn
Antispasmodic




Results from several in vitro studies generally indicate that feverfew reduces vascular smooth muscle spasm.nnThis inhibition is dose- and time-dependent: this action is due to the binding of the α-methylene-butyrolactone moiety to the thiol groups of proteins.nn
Usages associés
Safe dosage
Adults 18 years and older: 50 mg - 120 mg (standardized extract)
- Dose of 120 mg/day of leaf extract containing 0.20% parthenolide (minimum efficacy threshold in preparations based on dried leaves) - Whole herb: 2.5 g of leaves per day with a meal; - Cryo-dried leaf: 50 mg per day with a meal; - Powder: 50-120 mg per day equivalent to 0.2-0.6 mg of parthenolide.
Interactions
Médicaments
Antiplatelet agents/Anticoagulants: moderate interaction
Feverfew can inhibit platelet activity (a component that plays a role in blood clotting), so people taking anticoagulant medications (such as aspirin and warfarin) should consult a healthcare professional before taking this herb.
Precautions
Breastfeeding women: avoid
There is not enough information on the use of feverfew as a supplement for breastfeeding women.
Children up to 2 years: avoid
The use of feverfew in children under 2 years is not recommended.
Allergies: avoid
Feverfew is not recommended for people with a known allergy to Asteraceae.
Surgical intervention: avoid
Feverfew has antiplatelet effects. It can cause excessive bleeding if used before surgery.
Contraindications
Pregnant women: contraindicated
Feverfew is contraindicated during pregnancy. Feverfew can cause uterine contractions and miscarriage.
Oral: flowering tops, leaf
50 mg
12 weeks
dry extract
